NMN Anti-Aging Supplement Shows Promise in 90-Person Clinical Trial
First major clinical trial tests NMN supplement doses up to 900mg in middle-aged adults for anti-aging effects.
Supplements, peptides, nootropics, and bioactive compounds for health optimization
131 articles
First major clinical trial tests NMN supplement doses up to 900mg in middle-aged adults for anti-aging effects.
New study evaluates reduced nicotinamide mononucleotide for anti-aging benefits, measuring biological age and physical performance.
120-person trial tested whether Oligonol could reduce muscle loss and cardiovascular risks in middle-aged and older adults.
New evidence shows testosterone replacement safely improves muscle, mood, and metabolism in aging men when properly monitored.
Comprehensive review of 30+ years of research confirms creatine enhances performance, recovery, and health with no safety concerns.
New analysis reveals vitamin D supplementation dramatically reduces mortality in deficient populations, despite null results in sufficient groups.
New consensus reveals vitamin D supplementation may improve blood sugar control and reduce diabetes risk in prediabetic adults.
Eight-month study finds dietary interventions don't protect brain function or memory in Alzheimer's disease model rats.
Comprehensive review of 113 studies reveals NAD+ precursors are safe but clinical benefits for longevity remain unclear.
Expert analysis reveals why NAD's anti-cancer benefits may outweigh potential risks despite ongoing scientific debate.
Scientists discover how humanin peptide evolved differently in mammals to combat oxidative stress and protect cells from aging damage.